Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00654134 · ClinicalTrials.gov registry record · Phase 1
Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy Volunteers
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00654134 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants.
The verdict
NCT00654134, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the inflammatory response to 20,000 endotoxin units (EU) of CCRE (Clinical Center Reference Endotoxin) inhalation in a cohort of healthy volunteers. Preferably these subjects will have participated in ozone exposure studies, allowing a direct comparison of their responses to both endotoxin and ozone. Additionally, cardiovascular endpoints will be investigated with the CCRE exposure.
Interventions
- BIOLOGICAL Clinical Center Reference Endotoxin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-10 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00654134
The ClinicalTrials.gov registry entry for NCT00654134 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Center Reference Endotoxin is the first listed.
NCT00654134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00654134 about?
NCT00654134 is a clinical study titled "Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy Volunteers". The purpose of this study is to determine the inflammatory response to 20,000 endotoxin units (EU) of CCRE (Clinical Center Reference Endotoxin) inhalation in a cohort of healthy volunteers. Preferably these subjects will have participated in ozone exposure studies, allowing a direct comparison of t...
What is the current status of trial NCT00654134?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-10. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00654134?
The interventions under investigation include: Clinical Center Reference Endotoxin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00654134?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.